Captrust Financial Advisors Co Diagnostics, Inc. Transaction History

Captrust Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$3.76 - $6.29 $6,670 - $11,158	1,774 New	1,774 $10,000
Q4 2021 Feb 14, 2022	SELL	$8.12 - $10.37 $665 - $850	-82 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$7.48 - $11.38 $598 - $910	-80 Reduced 49.38%	82 $1,000
Q2 2021 Aug 16, 2021	BUY	$7.16 - $9.56 $766 - $1,022	107 Added 194.55%	162 $1,000
Q1 2021 May 17, 2021	SELL	$8.52 - $19.21 $3,791 - $8,548	-445 Reduced 89.0%	55 $1,000
Q2 2020 Aug 14, 2020	BUY	$7.46 - $23.42 $3,730 - $11,710	500 New	500 $10,000

4.3M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $35.8M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.